0.38089450366724514		SimpleArgument(Inc,List([45, 48)))	Relation([is] a wholly owned subsidiary of,List([8, 36)))	SimpleArgument(BioTex,List([37, 43)))	Ice9 is a wholly owned subsidiary of BioTex, Inc. (www.biotexmedical.com).
0.931028700145368		SimpleArgument(Ice9,List([0, 4)))	Relation(is,List([5, 7)))	SimpleArgument(a wholly owned subsidiary of BioTex, Inc,List([8, 48)))	Ice9 is a wholly owned subsidiary of BioTex, Inc. (www.biotexmedical.com).
0.9030401971054747		SimpleArgument(a spinoff,List([8, 17)))	Relation(focusing on,List([18, 26), [27, 29)))	SimpleArgument(commercialization of aptamer - based technologies,List([30, 79)))	Ice9 is a spinoff focusing on commercialization of aptamer discovery services and aptamer-based technologies.
0.9473416310728577		SimpleArgument(Ice Nine Biotechnologies Ice9,List([0, 4)))	Relation(is,List([5, 7)))	SimpleArgument(a spinoff focusing on commercialization of aptamer - based technologies,List([8, 79)))	Ice9 is a spinoff focusing on commercialization of aptamer discovery services and aptamer-based technologies.
0.9030401971054747		SimpleArgument(a spinoff,List([8, 17)))	Relation(focusing on,List([18, 26), [27, 29)))	SimpleArgument(commercialization of aptamer discovery services,List([30, 77)))	Ice9 is a spinoff focusing on commercialization of aptamer discovery services and aptamer-based technologies.
0.9181538107823964		SimpleArgument(Ice Nine Biotechnologies Ice9,List([0, 4)))	Relation(is,List([5, 7)))	SimpleArgument(a spinoff focusing on commercialization of aptamer discovery services,List([8, 77)))	Ice9 is a spinoff focusing on commercialization of aptamer discovery services and aptamer-based technologies.
0.3880890333449538		SimpleArgument(we,List([108, 110)))	Relation(can select,List([111, 121)))	SimpleArgument(aptamers at low cost,List([122, 142)))	Using a proprietary, high-throughput process for multiplexed discovery of aptamers to multiple targets, we can select aptamers at an unprecendented rate and low cost.
0.3880890333449538		SimpleArgument(we,List([108, 110)))	Relation(can select,List([111, 121)))	SimpleArgument(aptamers,List([122, 130)))	Using a proprietary, high-throughput process for multiplexed discovery of aptamers to multiple targets, we can select aptamers at an unprecendented rate and low cost.
0.9377201239337142		SimpleArgument(these same reagents,List([79, 98)))	Relation(are also valid drug leads in,List([64, 102), [103, 118), [119, 124)))	SpatialArgument(many cases,List([67, 77)))	In addition to rapid creation of affinity ligands for research, in many cases, these same reagents are also valid drug leads.
0.9111779447320654		SimpleArgument(these same reagents,List([79, 98)))	Relation(are also,List([99, 107)))	SimpleArgument(valid drug leads,List([108, 124)))	In addition to rapid creation of affinity ligands for research, in many cases, these same reagents are also valid drug leads.
